Comparing disability in activities of daily living over time among adults with advanced lung cancer or respiratory disease during the COVID-19 pandemic

King's College Hospital NHS Foundation Trust0 个研究点目标入组 120 人开始时间: 2020年12月14日最近更新: 2024年1月15日

试验速览

2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34382888/ (added 04/01/2024)

•1. Patients aged >18 years
•2. Advanced lung cancer or respiratory disease as defined by one of the following:
•2.1. Lung cancer: Inoperable stage III or IV non-small cell lung cancer
•2.2. Chronic Obstructive Lung Disease (COPD): Severe or very severe stages of COPD according to the criteria set by the Global Initiative for Chronic Obstructive Lung Disease (GOLD): stage III (FEV1/FVC <70%. 30% = FEV1 <50% predicted with or without chronic symptoms (cough, sputum production)) and stage IV (FEV1/FVC <70%. FEV1 <30% predicted plus chronic respiratory failure)
•2.3. Interstitial lung disease (ILD): Carbon monoxide transfer factor (TLCO/DLCO) level of <40% or FVC <50% predicted
•3. Patients with capacity to consent
•4. Patients with ability to understand and complete a questionnaire in English
•5. Life expectancy of >1 month as assessed by the person taking consent

•1. Patients aged <18 years
•2. Patients who lack the capacity to consent
•3. Patients who lack the ability to understand and complete a questionnaire in English
•4. Life expectancy of <1 month as assessed by the person taking consent

发起方